Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02192827 · ClinicalTrials.gov registry record · Phase 3
Use of Dexamethasone in Pediatric Asthma Exacerbations
A Phase 3 study, sponsored by University at Buffalo.
- Completed
- Registry status
- Phase 3
- Development phase
- 318
- Enrollment target
NCT02192827 is a Phase 3 study that has completed, run by University at Buffalo. The registered enrollment target is 318 participants.
The verdict
NCT02192827, a Phase 3 study, has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 318 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy of a single dose of dexamethasone vs. two doses of dexamethasone in mild and moderate asthma exacerbations pediatric patients.
Interventions
- DRUG Dexamethasone Sodium Phosphate Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2015-04 |
| Est. Completion | 2018-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02192827
The ClinicalTrials.gov registry entry for NCT02192827 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 318 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone Sodium Phosphate Injection is the first listed.
NCT02192827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02192827 about?
NCT02192827 is a clinical study titled "Use of Dexamethasone in Pediatric Asthma Exacerbations". The purpose of this study is to compare the efficacy of a single dose of dexamethasone vs. two doses of dexamethasone in mild and moderate asthma exacerbations pediatric patients.
What is the current status of trial NCT02192827?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 318 participants. The study started on 2015-04. Estimated completion is 2018-03.
What interventions are being tested in trial NCT02192827?
The interventions under investigation include: Dexamethasone Sodium Phosphate Injection (DRUG).
Who is sponsoring clinical trial NCT02192827?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.